Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARL | Q9H300 | 3/20 | 0.41 |
| ▸ | MGLL | Q99685 | 4/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | ATM | Q13315 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL29130624 | 0.91 | PARL (0.36) | PARLMGLLALOX12KMT2AATM | |
| SCHEMBL865136 | 0.90 | MGLL (0.40) | PARLMGLLCA12CA1CA9 | |
| Succinimide SCHEMBL6549250 | 0.88 | CRBN (0.42) | PARLMGLL | |
| SCHEMBL28964134 | 0.84 | MGLL (0.36) | PARLMGLLCA12CA1CA9 | |
| SCHEMBL57128 | 0.82 | PARL (0.38) | PARLMGLLCA12CA1CA9 | |
| Methacrylic Acid SCHEMBL27191395 | 0.82 | KMT2A (0.44) | PARLMGLLKMT2AATM | |
| SCHEMBL28377582 | 0.81 | MGLL (0.36) | PARLMGLL | |
| SCHEMBL10889616 | 0.81 | GLA (0.39) | PARLMGLLCA12CA1CA9 | |
| Bicarbonate SCHEMBL28277653 | 0.80 | MGLL (0.36) | PARLMGLLCA12CA1CA9 | |
| SCHEMBL1580294 | 0.80 | MGLL (0.38) | PARLMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 508 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3782653-B1 | COMPOSITION COMPRISING PEGYLATED ARGININE DEIMINASE | POLARIS GROUP (TW) | 2025-03-19 | — | — | EP | claimed |
| CN-115814163-B | PEG bi-component self-adhesive absorbable biological patch, and preparation method and application thereof | 北京博辉瑞进生物科技有限公司 | 2023-09-29 | — | — | CN | claimed |
| EP-3782653-A1 | COMPOSITION COMPRISING PEGYLATED ARGININE DEIMINASE | Polaris Group (CN) | 2021-02-24 | — | — | EP | claimed |
| EP-2834262-B1 | COMPOSITION COMPRISING PEGYLATED ARGININE DEIMINASE | POLARIS GROUP (CN) | 2020-09-02 | — | — | EP | claimed |
| CN-109072482-A | MULTIVALENT GLYCAN MICROARRAY PLATFORM | Z生物科技有限公司 | 2018-12-21 | — | — | CN | claimed |
| US-20180154008-A1 | METHODS OF TREATMENT WITH ARGININE DEIMINASE | POLARIS GROUP (KY) | 2018-06-07 | — | — | US | claimed |
| US-9731028-B2 | Methods of treatment with arginine deiminase | POLARIS GROUP (KY) | 2017-08-15 | — | — | US | claimed |
| US-20150132278-A1 | METHODS OF TREATMENT WITH ARGININE DEIMINASE | POLARIS GROUP (TW) | 2015-05-14 | — | — | US | claimed |
| EP-2834262-A1 | METHODS OF TREATMENT WITH ARGININE DEIMINASE | Polaris Group (CN) | 2015-02-11 | — | — | EP | claimed |
| WO-2013151568-A1 | METHODS OF TREATMENT WITH ARGININE DEIMINASE | POLARIS GROUP (CN) | 2013-10-10 | — | — | WO | claimed |
| US-6737259-B1 | MODIFIED WITH POLYETHYLENE GLYCOL FOR TREATMENT AND INHIBITION OF CANCER AND METASTASIS | PHOENIX PHARMACOLOGICS, INC. | 2004-05-18 | — | — | US | claimed |
| EP-1337630-A2 | MODIFIED ARGININE DEIMINASE | Phoenix Pharmacologics, Inc. (US) | 2003-08-27 | — | — | EP | claimed |
| US-20030082786-A1 | Compound for use in the treatment of gout and tumors | SHENYANG SUNSHINE PHARMACEUTICAL COMPANY LIMITED (CN) | 2003-05-01 | — | — | US | claimed |
| WO-2003011211-A2 | PEG-MODIFIED URICASE | PHOENIX PHARMACOLOGICS, INC. (US) | 2003-02-13 | — | — | WO | claimed |
| WO-2002044360-A2 | MODIFIED ARGININE DEIMINASE | PHOENIX PHARMACOLOGICS, INC. (US) | 2002-06-06 | — | — | WO | claimed |
| JP-2001524836-A | — | — | 2001-12-04 | — | — | JP | claimed |
| US-6183738-B1 | COVALENTLY BONDED TO POLYOXYETHYLENE GLYCOL VIA SUCCINIMIDE-TYPE LINKER; ANTITUMOR, ANTICARCINOGENIC, AND ANTIMETASTASIS AGENTS | PHOENIX PHARAMACOLOGICS, INC. | 2001-02-06 | — | — | US | claimed |
| EP-0981607-A1 | MODIIFIED ARGININE DEIMINASE | Phoenix Pharmacologics, Inc. (US) | 2000-03-01 | — | — | EP | claimed |
| WO-1998051784-A1 | MODIIFIED ARGININE DEIMINASE | PHOENIX PHARMACOLOGICS, INC. (US) | 1998-11-19 | — | — | WO | claimed |
| US-5446134-A | Reacting bis(fluorosulfonyl)methane salt with cyanogen halide or pseudohalide | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1995-08-29 | — | — | US | claimed |